keyword
https://read.qxmd.com/read/38630846/host-microbe-multiomic-profiling-reveals-age-dependent-immune-dysregulation-associated-with-covid-19-immunopathology
#1
JOURNAL ARTICLE
Hoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, Elias K Haddad, Patrice M Becker, Seunghee Kim-Schulze, Brian Lee, Jing Chen, Annmarie Hoch, Harry Pickering, Patrick van Zalm, Matthew C Altman, Alison D Augustine, Carolyn S Calfee, Steve Bosinger, Charles B Cairns, Walter Eckalbar, Leying Guan, Naresh Doni Jayavelu, Steven H Kleinstein, Florian Krammer, Holden T Maecker, Al Ozonoff, Bjoern Peters, Nadine Rouphael, Ruth R Montgomery, Elaine Reed, Joanna Schaenman, Hanno Steen, Ofer Levy, Joann Diray-Arce, Charles R Langelier
Age is a major risk factor for severe coronavirus disease 2019 (COVID-19), yet the mechanisms behind this relationship have remained incompletely understood. To address this, we evaluated the impact of aging on host immune response in the blood and the upper airway, as well as the nasal microbiome in a prospective, multicenter cohort of 1031 vaccine-naïve patients hospitalized for COVID-19 between 18 and 96 years old. We performed mass cytometry, serum protein profiling, anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays, and blood and nasal transcriptomics...
April 17, 2024: Science Translational Medicine
https://read.qxmd.com/read/38630829/dual-responsive-nanocarriers-for-efficient-cytosolic-protein-delivery-and-crispr-cas9-gene-therapy-of-inflammatory-skin-disorders
#2
JOURNAL ARTICLE
Echuan Tan, Tao Wan, Qi Pan, Jianan Duan, Song Zhang, Ruijue Wang, Peng Gao, Jia Lv, Hui Wang, Dali Li, Yuan Ping, Yiyun Cheng
Developing protein drugs that can target intracellular sites remains a challenge due to their inadequate membrane permeability. Efficient carriers for cytosolic protein delivery are required for protein-based drugs, cancer vaccines, and CRISPR-Cas9 gene therapies. Here, we report a screening process to identify highly efficient materials for cytosolic protein delivery from a library of dual-functionalized polymers bearing both boronate and lipoic acid moieties. Both ligands were found to be crucial for protein binding, endosomal escape, and intracellular protein release...
April 19, 2024: Science Advances
https://read.qxmd.com/read/38630789/facts-and-hopes-on-cancer-immunotherapy-for-small-cell-lung-cancer
#3
JOURNAL ARTICLE
Jon Zugazagoitia, Handerson Osma, Javier Baena, Álvaro C Ucero, Luis Paz-Ares
Platinum-based chemotherapy plus PD-1 axis blockade is the standard of care in the front-line treatment of extensive-stage small cell lung cancer (ES-SCLC). Despite the robust and consistent increase of long-term survival with PD-1 axis inhibition, the magnitude of the benefit from immunotherapy appears lower as compared to other solid tumors. Several immune evasive mechanisms have been shown to be prominently altered in human SCLC, including, among others, T cell exclusion, downregulation of components of the MHC-class I antigen processing and presentation machinery, or upregulation of macrophage inhibitory checkpoints...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38630618/genetics-of-immune-response-to-epstein-barr-virus-prospects-for-multiple-sclerosis-pathogenesis
#4
JOURNAL ARTICLE
Jesse Huang, Katarina Tengvall, Izaura Bomfim Lima, Anna Karin Hedström, Julia Butt, Nicole Brenner, Alexandra Gyllenberg, Pernilla Stridh, Mohsen Khademi, Ingemar Ernberg, Faiez Al Nimer, Ali Manouchehrinia, Jan Hillert, Lars Alfredsson, Oluf Andersen, Peter Sundström, Tim Waterboer, Tomas Olsson, Ingrid Kockum
Epstein-Barr virus (EBV) infection has been advocated as a prerequisite for developing multiple sclerosis (MS) and possibly the propagation of the disease. However, the precise mechanisms for such influences are still unclear. A large-scale study investigating the host genetics of EBV serology and related clinical manifestations, such as infectious mononucleosis (IM), may help us better understand the role of EBV in MS pathogenesis. This study evaluates the host genetic factors that influence serological response against EBV and history of IM and cross-evaluates them with MS risk and genetic susceptibility in the Swedish population...
April 17, 2024: Brain
https://read.qxmd.com/read/38630448/neutralizing-antibodies-to-interferon-alfa-arising-during-peginterferon-therapy-of-chronic-hepatitis-b-in-children-and-adults-results-from-the-hbrn-trials
#5
JOURNAL ARTICLE
Muhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, Alexander I Mosa, Loghman Salimzadeh, Robert P Perrillo, Raymond T Chung, Kathleen B Schwarz, Harry LA Janssen, Adam J Gehring, Jordan J Feld
BACKGROUND: Peginterferon-α (PegIFNα) is of limited utility during immunotolerant (IT) or immune active (IA) phases of chronic hepatitis B infection but is being explored as part of new cure regimens. Low/absent levels of IFNα found in some treated patients are associated with limited/no virological responses. AIM: To determine if sera from participants inhibit IFNα activity and/or contain therapy-induced anti-IFNα antibodies. METHODS: Pre-, on- and post-treatment sera from 61 IT trial participants on PegIFNα/ entecavir therapy and 88 IA trial participants on PegIFNα/tenofovir therapy were screened for anti-IFNα antibodies by indirect ELISA...
April 17, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38630135/intratumor-injection-of-bcg-ag85a-high-affinity-peptides-enhanced-anti-tumor-efficacy-in-ppd-positive-melanoma
#6
JOURNAL ARTICLE
Lanqun Qin, Guiying Zhang, Yirong Wu, Yueling Yang, Zhengyun Zou
As one of the scheduled immunization vaccines worldwide, virtually all individuals have been vaccinated with BCG vaccine. In order to verify the hypothesis that delivering BCG high-affinity peptides to tumor areas could activate the existing BCG memory T cells to attack tumor, we firstly predicted the HLA-A*0201 high-affinity peptides of BCG Ag85A protein (KLIANNTRV, GLPVEYLQV), and then, A375 melanoma cells and HLA-A*0201 PBMCs (from PPD-positive adults) were added to co-incubated with the predicted peptides in vitro...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38629371/translation-research-in-therapeutic-approaches-from-conventional-to-novel-nano-therapeutics-for-rheumatoid-arthritis-treatment
#7
JOURNAL ARTICLE
Laxmi Rani, Pooja Mathur, Ravinder Verma, Vivek Kumar, Ashwini Kumar Mishra, Pravat Kumar Sahoo
Rheumatoid arthritis is a systemic autoimmune disorder related to joint inflammation, bone erosion, and deformity. Numerous studies indicate that the causes and consequences of RA are still being debated, and therapeutic strategies are in the translation stage. Non-steroidal anti-inflammatory drugs continue to be often used to relieve pain. Still, due to their poor efficacy, failure to halt the spread of the disease, and undesirable adverse effects, they are no longer regarded as first-line treatments. The development of biologic DMRDs designed to reduce the inflammatory response led to substantial changes to the strategy for managing this disease...
April 15, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38629077/experimental-trials-of-predicted-cd4-and-cd8-t-cell-epitopes-of-respiratory-syncytial-virus
#8
JOURNAL ARTICLE
Syeda Tahira Qousain Naqvi, Syed Aun Muhammad, Jinlei Guo, Sidra Zafar, Amjad Ali, Larry J Anderson, Christina A Rostad, Baogang Bai
BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of viral lower respiratory tract infections (LRTIs) in young children around the world and an important cause of LRTI in the elderly. The available treatments and FDA-approved vaccines for RSV only lessen the severity of the infection and are recommended for infants and elderly people. METHODS: We focused on developing a broad-spectrum vaccine that activates the immune system to directly combat RSV...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38629061/the-role-of-b-1-cells-in-cancer-progression-and-anti-tumor-immunity
#9
REVIEW
Nely Rodríguez-Zhurbenko, Ana M Hernández
In recent years, in addition to the well-established role of T cells in controlling or promoting tumor growth, a new wave of research has demonstrated the active involvement of B cells in tumor immunity. B-cell subsets with distinct phenotypes and functions play various roles in tumor progression. Plasma cells and activated B cells have been linked to improved clinical outcomes in several types of cancer, whereas regulatory B cells have been associated with disease progression. However, we are only beginning to understand the role of a particular innate subset of B cells, referred to as B-1 cells, in cancer...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628552/-francisella-tularensis-specific-antibody-levels-in-sera-from-swedish-patients-with-suspected-tularemia-during-a-13-year-period
#10
JOURNAL ARTICLE
Helena Lindgren, Xijia Liu, Anders Sjöstedt
INTRODUCTION: For a majority of tularemia patients, serology is the basis for the diagnosis. The aim of this study was to perform an analysis of the samples analyzed at a Swedish reference laboratory for the presence of Francisella tularensis-specific antibody levels in sera from individuals with suspected tularemia. Annual and monthly variations of the total number of samples and proportions of positive samples were analyzed, as well as the influence of age and gender. METHODS: We performed a retrospective analysis of the presence of F...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38628551/a-novel-approach-to-designing-viral-precision-vaccines-applied-to-sars-cov-2
#11
JOURNAL ARTICLE
Khaled Trabelsi, Noureddin Ben Khalaf, Ahmed R Ramadan, Amany Elsharkawy, Dana Ashoor, Sadok Chlif, Thouraya Boussoffara, Melika Ben-Ahmed, Mukesh Kumar, M-Dahmani Fathallah
Efficient precision vaccines against several highly pathogenic zoonotic viruses are currently lacking. Proteolytic activation is instrumental for a number of these viruses to gain host-cell entry and develop infectivity. For SARS-CoV-2, this process is enhanced by the insertion of a furin cleavage site at the junction of the spike protein S1/S2 subunits upstream of the metalloprotease TMPRSS2 common proteolytic site. Here, we describe a new approach based on specific epitopes selection from the region involved in proteolytic activation and infectivity for the engineering of precision candidate vaccinating antigens...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38628411/monoclonal-antibodies-in-neuro-ophthalmology
#12
JOURNAL ARTICLE
Caroline C Keehn, Arman Yazdian, Patrick J Hunt, Pamela Davila-Siliezar, Noor A Laylani, Andrew G Lee
Neuro-ophthalmologic diseases include a broad range of disorders affecting the afferent and efferent visual pathways. Recently, monoclonal antibody (mAb) therapies have emerged as a promising targeted approach in the management of several of these complex conditions. Here, we describe the mechanism-specific applications and advancements in neuro-ophthalmologic mAb therapies. The application of mAbs in neuro-ophthalmologic diseases highlights our increasing understanding of disease-specific mechanisms in autoimmune conditions such as neuromyelitis optica, thyroid eye disease, and myasthenia gravis...
2024: Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society
https://read.qxmd.com/read/38628332/interstitial-keratitis-presenting-as-the-ocular-manifestation-of-undiagnosed-hidradenitis-suppurativa
#13
Kendahl Lyle, Joseph L Zimmer, Wesley M Gillette, Matthew S Recko
Interstitial keratitis is defined as nonulcerative inflammation of the corneal stroma resulting from a bacterial or viral infection, parasitic antigen, or autoimmune response. Hidradenitis suppurativa is an inflammatory skin condition that presents with painful and inflamed boils in apocrine gland-bearing regions of the body, typically with onset around puberty, and ocular comorbidities exist in only a small percentage of these patients. Herein, we describe a unique ocular presentation of hidradenitis suppurativa including pronounced bilateral interstitial keratitis and association with high titer c-ANCA (antineutrophil cytoplasmic antibodies)...
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38628115/effect-of-different-levels-of-single-cell-protein-and-probiotic-microorganisms-on-performance-immunological-responses-and-intestinal-histology-in-laying-hens
#14
JOURNAL ARTICLE
Rasoul Rashedi Dehsahraee, Amir Hossein Mahdavi, Mohammad Sedghi, Hassan Saleh
An experiment was conducted to evaluate the effects of single-cell protein (SCP), as a valuable by-product and substitute for soybean meal, and multistrain probiotics on the performance, blood biochemistry, intestinal histomorphology, ileal microbiota, and immune responses in laying hens. Leghorn laying hens were randomly assigned to nine experimental treatments with eight replicates of five birds each. Dietary treatments consisted of three levels of replacement of soybean meal with SCP (0.0%, 30%, and 60%) and three levels of probiotics (0...
April 17, 2024: Journal of Animal Physiology and Animal Nutrition
https://read.qxmd.com/read/38627681/efficacy-and-safety-of-bispecific-antibodies-vs-immune-checkpoint-blockade-combination-therapy-in-cancer-a-real-world-comparison
#15
REVIEW
Linyan Cheng, Lujun Chen, Yuan Shi, Weiying Gu, Weidong Ding, Xiao Zheng, Yan Liu, Jingting Jiang, Zhuojun Zheng
Emerging tumor immunotherapy methods encompass bispecific antibodies (BSABs), immune checkpoint inhibitors (ICIs), and adoptive cell immunotherapy. BSABs belong to the antibody family that can specifically recognize two different antigens or epitopes on the same antigen. These antibodies demonstrate superior clinical efficacy than monoclonal antibodies, indicating their role as a promising tumor immunotherapy option. Immune checkpoints are also important in tumor immunotherapy. Programmed cell death protein-1 (PD-1) is a widely acknowledged immune checkpoint target with effective anti-tumor activity...
April 16, 2024: Molecular Cancer
https://read.qxmd.com/read/38627386/emerging-variants-develop-total-escape-from-potent-monoclonal-antibodies-induced-by-ba-4-5-infection
#16
JOURNAL ARTICLE
Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, Daming Zhou, Alexander J Mentzer, Piyada Supasa, Muneeswaran Selvaraj, Helen M E Duyvesteyn, Thomas G Ritter, Nigel Temperton, Paul Klenerman, Susanna J Dunachie, Neil G Paterson, Mark A Williams, David R Hall, Elizabeth E Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I Stuart, Gavin R Screaton
The rapid evolution of SARS-CoV-2 is driven in part by a need to evade the antibody response in the face of high levels of immunity. Here, we isolate spike (S) binding monoclonal antibodies (mAbs) from vaccinees who suffered vaccine break-through infections with Omicron sub lineages BA.4 or BA.5. Twenty eight potent antibodies are isolated and characterised functionally, and in some cases structurally. Since the emergence of BA.4/5, SARS-CoV-2 has continued to accrue mutations in the S protein, to understand this we characterize neutralization of a large panel of variants and demonstrate a steady attrition of neutralization by the panel of BA...
April 16, 2024: Nature Communications
https://read.qxmd.com/read/38627380/host-response-during-unresolved-urinary-tract-infection-alters-female-mammary-tissue-homeostasis-through-collagen-deposition-and-timp1
#17
JOURNAL ARTICLE
Samantha Henry, Steven Macauley Lewis, Samantha Leeanne Cyrill, Mackenzie Kate Callaway, Deeptiman Chatterjee, Amritha Varshini Hanasoge Somasundara, Gina Jones, Xue-Yan He, Giuseppina Caligiuri, Michael Francis Ciccone, Isabella Andrea Diaz, Amelia Aumalika Biswas, Evelyn Hernandez, Taehoon Ha, John Erby Wilkinson, Mikala Egeblad, David Arthur Tuveson, Camila Oresco Dos Santos
Exposure to pathogens throughout a lifetime influences immunity and organ function. Here, we explore how the systemic host-response to bacterial urinary tract infection (UTI) induces tissue-specific alterations to the mammary gland. Utilizing a combination of histological tissue analysis, single cell transcriptomics, and flow cytometry, we identify that mammary tissue from UTI-bearing mice displays collagen deposition, enlarged ductal structures, ductal hyperplasia with atypical epithelial transcriptomes and altered immune composition...
April 16, 2024: Nature Communications
https://read.qxmd.com/read/38627377/neoadjuvant-tislelizumab-plus-stereotactic-body-radiotherapy-and-adjuvant-tislelizumab-in-early-stage-resectable-hepatocellular-carcinoma-the-notable-hcc-phase-1b-trial
#18
JOURNAL ARTICLE
Zhongchao Li, Jing Liu, Bo Zhang, Jinbo Yue, Xuetao Shi, Kai Cui, Zhaogang Liu, Zhibin Chang, Zhicheng Sun, Mingming Li, Yue Yang, Zhao Ma, Lei Li, Chengsheng Zhang, Pengfei Sun, Jingtao Zhong, Lei Zhao
Notable-HCC (NCT05185531) is a phase 1b trial, aiming to evaluate the safety and preliminary effectiveness of neoadjuvant PD-1 blockade plus stereotactic body radiotherapy (SBRT) in early-stage resectable hepatocellular carcinoma (HCC). Twenty patients with HCC of BCLC stage 0-A received 3 <mml:math xmlns:mml="https://www.w3.org/1998/Math/MathML"><mml:mo>×</mml:mo></mml:math> Gy SBRT and two cycles of tislelizumab, an anti-PD-1 monoclonal antibody before the curative HCC resection...
April 16, 2024: Nature Communications
https://read.qxmd.com/read/38627145/the-immunodominance-of-antigenic-site-sb-on-the-h1-influenza-virus-hemagglutinin-increases-with-high-immunoglobulin-titers-of-the-cohorts-and-with-young-age-but-not-sex
#19
JOURNAL ARTICLE
Jose L Martínez, Nicholas Lemus, Tsoi Ying Lai, Mitali Mishra, Irene González-Domínguez, Eduard Puente-Massaguer, Madhumathi Loganathan, Benjamin Francis, Marie I Samanovic, Florian Krammer, Mark J Mulligan, Viviana Simon, Peter Palese, Weina Sun
The head domain of the hemagglutinin of influenza viruses plays a dominant role in the antibody response due to the presence of immunodominant antigenic sites that are the main targets of host neutralizing antibodies. For the H1 hemagglutinin, five major antigenic sites defined as Sa, Sb, Ca1, Ca2, and Cb have been described. Although previous studies have focused on defining the hierarchy of the antigenic sites of the hemagglutinin in different human cohorts, it is still unclear if the immunodominance profile of the antigenic sites might change with the antibody levels of individuals or if other demographic factors (such as exposure history, sex, or age) could also influence the importance of the antigenic sites...
April 15, 2024: Vaccine
https://read.qxmd.com/read/38627054/extramedullary-relapse-of-multiple-myeloma-presenting-as-space-occupying-lesion-in-liver-treated-with-daratumumab-pomalidomide-dexamethasone-and-bendamustine
#20
JOURNAL ARTICLE
Sarthak Wadhera, Arihant Jain, Suvradeep Mitra, Pankaj Malhotra
Extramedullary relapse in patients with multiple myeloma (MM) is often associated with loss of biochemical response and the appearance of measurable residual disease in the bone marrow. Fever is an unusual presenting manifestation of MM. Treatment of extramedullary relapse in patients progressing on proteasome inhibitors, anti-CD38 monoclonal antibodies and immunomodulatory drugs is challenging, as access to chimeric antigen receptor T-cells and bispecific antibodies is limited. We report a case of relapsed MM who presented with fever and hepatic space-occupying lesion mimicking hepatocellular carcinoma...
April 16, 2024: BMJ Case Reports
keyword
keyword
19050
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.